Maintenance fees coming due
34 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Nov 19, 2026. Unpaid by May 19, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 9,034,331 | Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force Fee due Nov 19, 2026 Lapses if unpaid May 19, 2027 · High confidence | Kymab Limited | In force | Nov 19, 2026 | May 19, 2027 | High confidence | |
| US 9,034,332 | Precision Medicine by Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force Fee due Nov 19, 2026 Lapses if unpaid May 19, 2027 · High confidence | Kymab Limited | In force | Nov 19, 2026 | May 19, 2027 | High confidence | |
| US 9,040,052 | Precision Medicine By Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force Fee due Nov 26, 2026 Lapses if unpaid May 26, 2027 · High confidence | Kymab Limited | In force | Nov 26, 2026 | May 26, 2027 | High confidence | |
| US 9,045,545 | Precision Medicine by Targeting PD-L1 Variants for Treatment of Cancer In force Fee due Dec 2, 2026 Lapses if unpaid Jun 2, 2027 · High confidence | Kymab Limited | In force | Dec 2, 2026 | Jun 2, 2027 | High confidence | |
| US 9,045,548 | Precision Medicine By Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force Fee due Dec 2, 2026 Lapses if unpaid Jun 2, 2027 · High confidence | Kymab Limited | In force | Dec 2, 2026 | Jun 2, 2027 | High confidence | |
| US 9,051,378 | Targeting rare human PCSK9 variants for cholesterol treatment In force Fee due Dec 9, 2026 Lapses if unpaid Jun 9, 2027 · High confidence | Kymab Limited | In force | Dec 9, 2026 | Jun 9, 2027 | High confidence | |
| US 11,680,101 | Anti-Opg Antibodies In force Fee due Dec 20, 2026 Lapses if unpaid Jun 21, 2027 · High confidence | Kymab Limited | In force | Dec 20, 2026 | Jun 21, 2027 | High confidence | |
| US 9,062,105 | Precision Medicine by Targeting VEGF-A Variants for Treatment of Retinopathy In force Fee due Dec 23, 2026 Lapses if unpaid Jun 23, 2027 · High confidence | Kymab Limited | In force | Dec 23, 2026 | Jun 23, 2027 | High confidence | |
| US 9,067,998 | Targeting PD-1 Variants for Treatment of Cancer In force Fee due Dec 30, 2026 Lapses if unpaid Jun 30, 2027 · High confidence | Kymab Limited | In force | Dec 30, 2026 | Jun 30, 2027 | High confidence | |
| US 9,068,012 | Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force Fee due Dec 30, 2026 Lapses if unpaid Jun 30, 2027 · High confidence | Kymab Limited | In force | Dec 30, 2026 | Jun 30, 2027 | High confidence | |
| 24 more maintenance fees coming due in the 12 months from Nov 15, 2026 · Pro | |||||||
10 of 34 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.